vimarsana.com
Home
Live Updates
Zomedica Announces Preliminary 2023 Revenue; Provides Revenu
Zomedica Announces Preliminary 2023 Revenue; Provides Revenu
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")
ANN ARBOR, MI / ACCESSWIRE / January 17, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine
Related Keywords
Michigan ,
United States ,
Ann Arbor ,
American ,
Larry Heaton ,
Zomedica Corp ,
Investor Relations Zomedica Inc ,
New York Stock Exchange ,
Equity Research Analyst Coverage ,
York Stock Exchange ,
Therapeutic Device ,
Therapeutic Devices ,
Cash Equivalents ,
Available For Sale Securities ,
Zomedica Chief Executive Officer ,
Special Virtual Only Meeting ,
Broader Range ,
Stock Indices Inclusion ,
Special Meeting ,
Proxy Circular ,
Investor Relations ,
Zomedica Corporate Website ,
Business Update Conference Call ,
Zomedica Business Update ,
Statement Regarding Forward Looking Statements ,
Region ,